GNAQ/11 mutations in uveal melanoma: Is YAP the key to targeted therapy?

20Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

Abstract

GNAQ and GNA11 are frequently mutated in uveal melanoma, but they remain difficult therapeutic targets. In this issue of Cancer Cell, Feng and colleagues and Yu and colleagues demonstrate that the oncogenic activity of mutant GNAQ/11 is mediated at least in part through YAP, potentially uncovering a new therapeutic strategy. © 2014 Elsevier Inc.

Cite

CITATION STYLE

APA

Field, M. G., & Harbour, J. W. (2014, June 16). GNAQ/11 mutations in uveal melanoma: Is YAP the key to targeted therapy? Cancer Cell. Cell Press. https://doi.org/10.1016/j.ccr.2014.05.028

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free